tiprankstipranks
Advertisement
Advertisement
Krystal Biotech price target raised to $386 from $378 at Citi
PremiumThe FlyKrystal Biotech price target raised to $386 from $378 at Citi
20d ago
Analyst Backs Krystal with Buy Rating on Vyjuvek Launch Momentum and Rare-Disease Pipeline Upside
Premium
Ratings
Analyst Backs Krystal with Buy Rating on Vyjuvek Launch Momentum and Rare-Disease Pipeline Upside
21d ago
Morning Movers: Supernus and Indivior jump following merger pact
Premium
The Fly
Morning Movers: Supernus and Indivior jump following merger pact
21d ago
Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24
PremiumThe FlyTutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24
1M ago
Krystal Biotech price target raised to $396 from $364 at BofA
Premium
The Fly
Krystal Biotech price target raised to $396 from $364 at BofA
1M ago
Krystal Biotech price target raised to $474 from $399 at Jefferies
Premium
The Fly
Krystal Biotech price target raised to $474 from $399 at Jefferies
1M ago
Krystal Biotech announces UK MHRA approval of Vyjuvek
PremiumThe FlyKrystal Biotech announces UK MHRA approval of Vyjuvek
3M ago
U.K.’s MHRA approves Krystal’s Vyjuvek for dystrophic epidermolysis bullosa
Premium
The Fly
U.K.’s MHRA approves Krystal’s Vyjuvek for dystrophic epidermolysis bullosa
3M ago
Krystal Biotech price target raised to $300 from $295 at Evercore ISI
Premium
The Fly
Krystal Biotech price target raised to $300 from $295 at Evercore ISI
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100